Southern Acids (M) Berhad Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Southern Acids (M) Berhad has a total shareholder equity of MYR870.9M and total debt of MYR20.6M, which brings its debt-to-equity ratio to 2.4%. Its total assets and total liabilities are MYR1.0B and MYR144.5M respectively. Southern Acids (M) Berhad's EBIT is MYR35.3M making its interest coverage ratio 41.2. It has cash and short-term investments of MYR381.4M.
Anahtar bilgiler
2.4%
Borç/özkaynak oranı
RM 20.60m
Borç
| Faiz karşılama oranı | 41.2x |
| Nakit | RM 381.40m |
| Eşitlik | RM 870.92m |
| Toplam yükümlülükler | RM 144.53m |
| Toplam varlıklar | RM 1.02b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Southern Acids (M) Berhad's (KLSE:SAB) Soft Earnings Are Actually Better Than They Appear
Mar 03
If You Like EPS Growth Then Check Out Southern Acids (M) Berhad (KLSE:SAB) Before It's Too Late
May 27The Returns At Southern Acids (M) Berhad (KLSE:SAB) Aren't Growing
Apr 19Are Strong Financial Prospects The Force That Is Driving The Momentum In Southern Acids (M) Berhad's KLSE:SAB) Stock?
Feb 24Returns On Capital At Southern Acids (M) Berhad (KLSE:SAB) Paint An Interesting Picture
Jan 13What Can We Learn About Southern Acids (M) Berhad's (KLSE:SAB) CEO Compensation?
Dec 15
Southern Acids (M) Berhad (KLSE:SAB) Share Prices Have Dropped 14% In The Last Three Years
Nov 24Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: SAB's short term assets (MYR614.0M) exceed its short term liabilities (MYR109.5M).
Uzun Vadeli Yükümlülükler: SAB's short term assets (MYR614.0M) exceed its long term liabilities (MYR35.0M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: SAB has more cash than its total debt.
Borcun Azaltılması: SAB's debt to equity ratio has increased from 0% to 2.4% over the past 5 years.
Borç Kapsamı: SAB's debt is well covered by operating cash flow (110.5%).
Faiz Kapsamı: SAB's interest payments on its debt are well covered by EBIT (41.2x coverage).